FreeTender
Accepting bidsgrantUnited States

Specialized Alcohol Research Centers (P50 Clinical trial Optional)

Issued by National Institutes of Health · via Grants.gov — US federal funding opportunities

Published
15 Oct 2026
Closes
27 Jan 2027, 23:59 UTC
Value
USD 1,500,000
Reference
RFA-AA-28-001
Location
United States
Sector
Healthcare & Pharma

At a glance

National Institutes of Health in United States has published a funding call in healthcare & pharma: “Specialized Alcohol Research Centers (P50 Clinical trial Optional)”. Submissions close on 27 January 2027, 103 days from today. The stated value is USD 1,500,000. Quote reference RFA-AA-28-001 in any correspondence with the buyer. FreeTender has recorded 442 notices from this buyer since 2023, 381 of them currently open. There are 370 open healthcare & pharma notices in United States on FreeTender. Bids are submitted to the buyer through Grants.gov — US federal funding opportunities, not through FreeTender.

Details

The National Institute on Alcohol Abuse and Alcoholism (NIAAA) supports a broad-based Alcohol Research Centers program to foster and conduct interdisciplinary, collaborative research on alcohol misuse, Alcohol Use Disorder (AUD), and alcohol-related problems, and other health-related consequences across the lifespan. The NIAAA Centers Program provides leadership in research, and research methodology development on a wide variety of topics relevant to the Institute's mission. The focus of the NIAAA Centers program should be on generating a critical mass of researchers in a given understudied and/or innovative topic area relevant to the NIAAA mission with an emphasis on interdisciplinary coordination and cooperation among independent researchers and development and mentorship of young investigators. A center must contribute more to the alcohol field than the sum of its parts. Topics include but are not limited to, the nature, etiology, genetics, diagnosis, treatment, and prevention of alcohol misuse, AUD, alcohol-related end-organ diseases, and their biomedical, psychosocial, and population health consequences across the lifespan. Centers are also major contributors to the development of research methods, technologies, and approaches that sustain innovative goal-directed research on understanding the chronic disorder of alcohol misuse that is such a personal, social and medical burden to US society. Eligibility: Refer to Section III. Eligibility Information in the NOFO for additional information on eligibilityForeign Organizations/International CollaborationsNon-domestic (non-U.S.) Entities (Foreign Organization) are not eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.

Estimated total programme funding: USD 1500000

CFDA number(s): 93.273

Federal funding opportunity published on Grants.gov. Applications are submitted through Grants.gov — see the official listing.

Context for bidders

We hold 442 notices from National Institutes of Health, going back to May 2023 — 381 of them still open. They buy mostly in Healthcare & Pharma, Education & Training and Water & Environment. There are 370 open Healthcare & Pharma tenders in United States. This one closes in 103 days.

Before you bid on this tender

A quick checklist to help you decide whether to bid and prepare a compliant submission for this healthcare & pharma opportunity. Always verify the details on the official source.

  • Confirm the exact closing date and time (and time zone) on the official portal — deadlines are strict and can be revised by a corrigendum.
  • Read the full notice and every attached document, including the scope, specifications and any bill of quantities or terms of reference.
  • Check the eligibility criteria — prior similar experience, annual turnover, certifications and registrations — and make sure you qualify before investing effort.
  • Prepare any earnest-money deposit (EMD) or bid security and the required formats early; missing or wrongly-formatted documents are a common cause of rejection.
  • Note how bids must be submitted (online or physical), in what format, and whether a digital signature or portal registration is required.
  • Watch for corrigenda and clarifications right up to the deadline — requirements and dates can change.

More Healthcare & Pharma tenders

All Healthcare & Pharma tenders →

FreeTender mirrors this notice for reference. Verify the details and bid on the official portal.

Verify & apply on the official portal →